Hotcopper spl. Last edited by sarge17: 28/11/22. Hotcopper spl

 
 Last edited by sarge17: 28/11/22Hotcopper spl 32 , that is a daily rise of over 50% on the market capital at the time it hit that low

Created with Sketch. Commodities. Forums. Market . ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. Their IP doesn't last forever - you need to hustle in pharma. I recommend that everyone sees the below. Resolutons 2,3 &4. Energy. Latest Posts. Jackie in the discussion talked about dealing with the tourist industry. Last edited by sarge17: 28/11/22. , page-4. SPL always has tantalising carrots to dangle before the eyes of investors. . SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. ASX - Short Term Trading. Attached link highlights some of the complexities involved more broadly. 5. Market . All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. HotCopper is an Australian stock market online chat forum that allows its users to discuss financial topics. . Join the HotCopper ASX share market forum today for free. Latest Posts. Created with Sketch. 9¢. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. ASX - By Stock. The news flow coming from SPL of latehas been lackluster at best. Forums. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. ASX - By Stock. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. Forums. Last updated 10. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. Click for more information. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. My theory is we had a large accumulator that was content buying. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. As of 2015, HotCopper was in the top 170 websites in Australia and was. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Charts. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. 615, today the share price rose by 0. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 0 Great. municipal. 57. Eight (8) contributors to the HC SPL thread made price predictions (thank. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. Our magic little formula may just be the answer. No change of interest notification received. And he still is Chairman or Director of SIX other companies. 13. 16,364,160. . HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . ASX - Day TradingCreated with Sketch. ASX - Day Trading. 50 or thereabouts. SPL Price at posting: 91. Even if these collaborations have beenterminated, the market deserves to know about it. Just begin to imagine that all staff on board use Viraleze well before. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. 8¢. They need IMO to define good and any other qualifying words !!. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. I no longer regard SPL as an investment-grade stock. ASX - By Stock. 59pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. 45K. ASX - By Stock. and I dont like what I am seeing. I think that the more time that passes without profits, the less likely that there will ever be profits. Forums. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. ASX - By Stock. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - General. Last edited by antibotter : 13/11/23. For a small cap like spl where the revenue stream created would be very large in the context of our current. 0834. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. 362771. ASX - Day Trading. , page-2. . Target our investor community with our suite of Hotcopper Advertising opportunities. My last 350 posts take me back over two years and cover about twenty different stocks. 45K. 55pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Created with Sketch. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. Forums. And somebody must be buying all the shares that are being sold. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. Is this a case of short memories? The best one can say is her surprise is disingenuous. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. 3¢. 0000. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. More. ASX - General. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. ASX - By Stock. 75. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. ASX - General. I should declare that I am. MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. Talk with one of our capital market experts to learn more about our innovative and. 5. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - By Stock. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Latest Posts. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is different SPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Latest Posts. Share In the last year we have seen the resignation of the Head of Research, David Owen and now the Chief Financial Officer, Nigel Baade. , Inc. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Created with Sketch. ACCELERATE RESOURCES LIMITED. Hey, "smart", I concur with your message. Created with Sketch. . All that seems to happen is that new verses are sometimes added. m. 5¢. $-0. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 72. Advertise on HotCopper. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. 6% (1. In SPL's case there is clearly another. However, just a word of caution before the usual pumping starts by the usual suspects. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. . Today it closes up 5% on the high of the bar and all we here. 17112. SPL Price at posting: 44. Zeus Resources Limited is an Australia-based mineral exploration company. ASX - General. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 11%. SPL Price at posting: 71. 4¢. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. . Last updated 15. Created with Sketch. Created with Sketch. Last updated 15. 0¢. 5. ASX - Short Term Trading. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. Created with Sketch. . Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. 06B ! Add to my watchlist. ASX - By Stock. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. 0¢. Merck -- 2. ASX - By Stock. Created with Sketch. Charts. Market Cap $57. It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. Market . Market Cap $58. Share It would be silly to be tight on cash. 63M. 0. Target our investor community with our suite of Hotcopper. ASX - Short Term Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . We know that they haven't been marketed well but i think BigPharma have had an input. Views. Interesting write-up. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. This is a charting thread for those interested in the movements of the SPL SP. 48. More. 4. SPL scientists will no doubt be working on this right now. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. Created with Sketch. Target our investor community with our. The matter has been adjourned to. 13. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Some links within this article worth a scan too. Forums. Created with Sketch. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. Enter the title of your abstract. We would like to show you a description here but the site won’t allow us. ASX - General. Last updated 15. Imo HotCopper posters must have an. ASX - Day Trading. Join the HotCopper ASX share market forum today for free. Last updated 15. . News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. 68. ASX - General. NSX - By Stock. DISCOVER THE BATTERY METALS REVOLUTION. . . Created with Sketch. but have sent email to other companies CEO etc too, with some response, but all are dead end reply or will address and get in contact soon. This is a charting thread for those interested in the movements of the SPL SP. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. Market. ASX - By Stock. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . In March 2020 the SPL share price dropped to a low of 0. Advertise on HotCopper. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. Advertise. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. ASX - By Stock. The Company is. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. It’s incredibly important to keep us informed. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. There appears to be a different behavioural feel about. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. - 12:30 p. . Created with Sketch. I hope I'm wrong here. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. A correctly formatted example follows: Title of my presentation for the conference. Advertise on HotCopper. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. Created with Sketch. Hey, "smart", I concur with your message. Click for. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. Forums. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. The recent announcement about Viraleze nasal. Created with Sketch. 57pm 13/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Latest Posts. SUBMISSION STEPS. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. ASX - Day Trading. . Nope. DISCOVER THE BATTERY METALS. HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Volume. 48. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. yet if one considers that the amount of millions of shares via option they. Enter the title of your abstract. 00. The upper and lower pennant lines will intersect in three months. 0¢. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. Forums. Created with Sketch. They are the future as also mentioned regularly by Eric Topol. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Ena Respiratory is getting news coverage everywhere - newspapers, onilne, 7 morning news, more coverage than I've seen for SPL - “By boosting the natural immune response of the ferrets with our treatment, we’ve seen a rapid eradication of the virus,” he explained in a statement. Last updated 10. I saw that some director etc invested there own money in the SPP etc,. ASX - Day Trading. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. ASX - General. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. In part it oversees accelerated research initiatives to develop responses to unmet needs. and as I said I met @Domesticgod there, which was a pleasure. 3¢. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. Created with Sketch. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. . SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Forums. . Latest Posts. . Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. CEO knows it is all going. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. ASX - Day TradingCreated with Sketch. Click for more information. Created with Sketch. Market Cap $. I have just sent. The last time was December 2018. 40. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. 1. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. Created with Sketch. 49M. 5¢. 9¢. That's how markets work sometimes. Volume. 57% 13. MarketDep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. The total and absolute shame of this is that not once in their quarter of a century of existence have these "discussions" amounted to a deal. But the products were developed as proof of a saleable dendrimer product. 6. . It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. . Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. ,), Okamoto, LifeStyles, Aspen and Mundipharma. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. ASX - Day Trading So the share price of SPL rose up to a high of $2. * The Viraleze trial will be completed. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. So far no one wants to add anything except to get. Created with Sketch. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. OR no reponse at all. 1. Latest Posts. Created with Sketch. My portfolio has risen 95% since I sold SPL with conviction. Created with Sketch. Hotcopper has reinvented itself as The Market Herald with an ASX code of TMH The company has an online news site called The Market Herald Below is a. ASX - By Stock.